Clinical Trial Update: Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Oxymetazoline HCl 1.0% cream in persistent facial erythema associated with rosacea; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythema
• Rosacea

Drugs mentioned

• Oxymetazoline HCl Cream 1.0% (oxymetazoline hydrochloride)

Snippet

Sponsor: Allergan | Conditions: Erythema, Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2016-08-02